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ABSTRACT 
Dengue is a mosquito-borne disease of public health importance. It is caused by four serotypes of 
Dengue virus (i.e. DENV-1, -2, -3 and -4). As a result of practices that are conducive for mosquito 
breading, its vector is widespread in Nigeria and this could result to possible DENV outbreaks in 
Nigeria and beyond. This study aimed to assess the recency of DENV infection as well as occurrence 
of DENV and Malaria co-infections within Ilorin, Nigeria. Blood samples were obtained from 176 
febrile subjects and analyzed using Enzyme Linked Immunosorbent Assay (ELISA) for the presence 
of DENV antibodies. Malaria infection was detected using a rapid diagnostic test kit for malaria 
parasites. Malaria and DENV (IgM positive) co-infected samples were further subjected to RT-qPCR 
analysis. A seroprevalence of 46.0% was recorded for anti-DENV IgM antibodies and 2.84% for 
concurrent dengue and malaria infections. Out of 95 IgM negative samples, 48 were found to be 
positive for DENV IgG antibodies. Eleven (6.25%) samples were confirmed DENV positive 
following RT-qPCR. The CT values of the amplicons were between 19.0 and 20.0. DENV serotype 2 
dominated the study, while serotype 3 and 4 were equally distributed. Based on the high 
seroprevalence of DENV obtained in this study, there is a high possibility of experiencing Dengue 
virus outbreak in Ilorin, Nigeria, not neglecting the fast geographical spread of the vector. Therefore, 
surveillance and intensive vector control program should be instituted
KEYWORDS 
Flavivirus; Immunoglobulin; RNA Extraction; Seroprevalence
TEXT 
1. INTRODUCTION 
Dengue was classified by the World Health Organization (WHO) in 2012 as the most important 
mosquito-borne viral disease in the world [WHO, 2012]. Aedes aegypti is the principal vector of 
Dengue. Dengue virus (DENV) belongs to the genus Flavivirus within the Flaviviridae family. It is 
circular in shape and contains an envelope covered with two viral proteins (E and M). These proteins 
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enable viral attachment and establishment of infection [Perera and Kuhn, 2008]. 
Dengue virus has four serotypes (DEN 1-  LQIHFWLRQ ZLWK RQH GRHVQ¶W Srovide immunity against 
others. Each DENV serotypes has about 65% similarity in their viral genome, which is approximately 
the same degree of genetic relatedness Japanese encephalitis virus has in common with West Nile 
virus. Each DENV serotype causes similar symptoms in humans and circulates in the same ecological 
niche [Walts et al., 1987]. Dengue hemorrhagic fever (DHF) and Dengue Shock Syndrome (DSS- 
Complicated case of DENV) were first noted among some Americans in 1981 when DENV-2 was 
contracted by people who had previously been infected with DENV-1 some years earlier [Gould et 
al., 2008]. Several observations by scholars have led to a conclusion that subsequent infection of 
preimmune individuals with a different DENV serotype could exacerbate rather than mitigate disease, 
a process caused by antibodies and termed antibody- dependent enhancement (ADE) of disease 
[Halstead, 1970]. 
The first documented report of DENV in Africa was an isolate from Ibadan, Nigeria around 1960. 
There are few countries with no reported cases of dengue virus in Africa [Amarasinghe et al., 2011]. 
For several decades, DENV outbreaks have persistently occurred in some part of  
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Africa (Nigeria inclusive), but possibly go unreported due to diagnostic inadequacies and/ or 
underreporting [Baba et al., 2016]. 
Malaria is the most prevalent infectious disease in the tropical and subtropical regions of the world, 
and has a high morbidity especially in tropical countries [Mishra et al., 2003]. In those who have 
recently survived an infection, re-infection typically causes milder symptoms. This partial resistance 
disappears over months to years if the person has no continuing exposure to malaria [Caraballo and 
King, 2014]. 
Although infection with dengue or malaria can be life-threatening, co-infections with DENV and 
malaria could be more severe (Epelboin et al., 2012). Owing to the similar symptoms common to 
DENV- and malaria-infected individuals, misdiagnosis of either, and/ or co-infections have informed 
the need for a differential diagnostic approach especially in DENV-/ malaria-endemic regions 
(Magalhaes et al., 2014). This study sought to investigate the incidence of co-infections with DENV 
and malaria parasites in Ilorin, Nigeria, as well as the immunological status of febrile subjects against 
DENV infections in Ilorin, Nigeria. 
2. MATERIALS AND METHODS 
2.1 STUDY DESIGN 
This study adopted a cross-sectional design that included prospective hospital-based surveillance of 
cases among febrile participants attending three major health facilities within Ilorin metropolis, 
Kwara State, Nigeria. This study was conducted within the peak period of the dry season (January - 
February, 2016).  
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2.2 STUDY AREA 
Kwara state occupies a key position in North-central Nigeria. It borders Benin Republic to the West 
as well as five Nigerian states, to the North (i.e. Niger state), East (i.e. Kogi state) and South (i.e. 
Ekiti, Osun and Oyo states). These borders make the efflux and influx of people easy. This study was 
conducted within the state capital which covers two (2) Local Government Areas of Kwara state 
[Ilorin East (80¶10¶(DQG,ORULQ6RXWK0¶10¶(@1LJHULD7KHFOLPDWLFFRQGLWLRQRI
the North-central region of Nigeria (including Kwara state) is dominated by the influence of three 
major wind currents, namely: the maritime tropical (mT) air mass, the continental tropical (cT) air 
mass and the equatorial easterlies. The rainy seasons begin in March and end in October. The 
population of Ilorin East and Ilorin South was estimated to be 207,462 and 209,251 respectively 
[NPC, 2006]. 
2.3 STUDY POPULATION 
A total of 176 participants were recruited for this study at three health centers within Ilorin 
metropolis. The inclusion criteria, which was based on their medical history and malaria 
symptomatology, included ongoing febrile illness, suspected to be malaria, typhoid or pyrexia of 
unknown origin at three health centers within Ilorin metropolis. This category of subjects was selected 
because the prodrome stage of Dengue and these diseases is similar. The study population included 
males and females from all age group. 
2.4 SAMPLE COLLECTION 
Blood sample of about 5ml was collected intravenously using sterile syringes from febrile patients 
into Ethylene Diamine Tetra-acetic Acid (EDTA) anti-coagulant bottles. The samples
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collected were centrifuged at 3000 r.p.m. for 5 minutes and the plasma was carefully harvested into 
sterile tubes. The plasma was stored at -800C until needed for assay. A closed-ended questionnaire 
was administered to participants in order to harvest socio-demographic data, as well as DENV/malaria 
predisposing risk factors. 
2.5 DETECTION OF IgM AND IgG ANTIBODIES AGAINST DENGUE VIRUS 
In order to diagnose recent cases of dengue, plasma samples of study participants were screened for 
the presence of anti-DENV IgM antibodies using a commercial Human Dengue IgM ELISA kit 
:.($0('6833/,(6&253&KLQD DFFRUGLQJ WR WKHPDQXIDFWXUHU¶V LQVWUXFWLRQV ,QRUGHU WR
detect past infections, plasma samples that tested negative for anti-DENV IgM were screened for anti-
DENV IgG using a commercial Human Dengue fever IgG (DF-IgG) ELISA Kit [Antibodies-online 
GmbH, Germany@DFFRUGLQJWRWKHPDQXIDFWXUHU¶VLQVWUXFWLRQV 
2.6 MALARIA PARASITE SCREENING 
In other to investigate the occurrence of concurrent infections, subjects that tested positive for recent 
DENV infection were screened for malaria parasite (MP). The MP screening was conducted using a 
&DUH6WDUW 0DODULD +53 3) UDSLG GLDJQRVWLF NLWV 1HZ -HUVH\ 86$ IROORZLQJ WKH
PDQXIDFWXUHU¶VLQVWUXFWLRQ. 
2.7 MOLECULAR CHARACTERIZATION OF DENGUE VIRUS 
6XEMHFWV¶VDPSOHVFROOHFWHGZLWKLQWKHILUVWGD\VRILOOQHVVZHUHVXEMHFWHGWRPROHFXODUGLDJQRVLVRI
DENV infections by RT-qPCR. RNA extraction was carried out using RNeasy mini
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kits (Qiagen, Maryland, USA) according to the specifications of the manufacturer. The extracted 
RNA was preserved at -80°C until needed for further assay. 
RT- qPCR FOR DETECTION AND SEROTYPING OF DENGUE VIRUS 
The Dengue virus primers (DENV_F- GCATATTGACGCTGGGARAGAC, DENV_R1-3- 
TTCTGTGCCTGGAATGATGCTG, DENV_R4- YTCTGTGCCTGGATWGATGTTG) and probe 
(DENV_P- &$*$*$7&&7*&7*7&XVHGZHUHGHVLJQHGWRWDUJHWWKH¶XQWUDQVODWHGUHJLRQDQG
was obtained from INQABA BIOTECH, South Africa. The PCR reaction mixture contained 12.5 pL 
of Maxima SYBR Green qPCR master mix (2.5mM MgCh, dNTP, dUNTP, Maxima Hot Start Taq 
DNA polymerase, SYBR Green I dye), 0.3 pM of the sense and antisense primers, 500 ng of the 
extracted RNA and 4.5pL of PCR grade water to make a final volume of 25 pL. The PCR mixture 
was introduced into a thermocycler (iCycler) (Bio-Rad, USA) programmed to incubate for 60 minutes 
at 37oC and 10 minutes at 95oC to allow cDNA production and initial denaturation and then proceed 
with 40 cycles of denaturation (95oC for 30s), primer annealing (65oC for 60s), primer extension 
(72oC for 7 mins) and the amplicon maintained at 4oC. The four dengue virus serotypes was 
differentiated as illustrated by (Rahman et al., 2013). 
2.8 DATA ANALYSIS 
Data generated in this study were entered and analyzed in Microsoft Excel 2007 and Statistical 
Package for the Social Sciences (SPSS) version 21.0. Descriptive statistics including average and 
proportion was used to summarize the data. Pearson Chi-square test of significance was applied. A 
95% confidence interval (P< 0.05) was considered statistically significant.  
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2.9 ETHICAL CLEARANCE 
An ethical clearance for the study was obtained from the Ethical Review Committee (ERC) of Kwara 
state Ministry of Health, Nigeria, and from the respective hospitals included in this study. Informed 
consent was obtained from study participants on voluntary basis. 
3. RESULTS 
In this study, 76 (43.2%) subjects tested positive to anti-DENV IgM only, while 5 (2.8%) subjects 
tested positive to anti-DENV IgM and MP (Figure I). Out of the 95 IgM negative samples, 48 were 
found to be positive for dengue virus IgG antibodies (Figure II). However, four samples were not 
assayed for dengue virus IgG antibodies due to insufficient plasma. Out of 18 samples selected for 
RT-qPCR, 6 (five of which were IgM positive) had insufficient plasma and were thus excluded from 
the RT-qPCR assay. 
Females were more seropositive (54.3%) to recent dengue mono-infection while the males accounted 
for 45.6% (Table I). The total number of females who were screened for Dengue virus infection was 
slightly higher than the males. There was no statistical association between Dengue virus IgM 
DQWLERGLHVVHURVWDWXVDQGVXEMHFWV¶VH[;2= 0.150, P=0.698). 
The seroprevalence of recent Dengue virus infection with respect to age showed that all age groups 
had individuals who were seropositive for the virus. Subjects in the age group 31-40 had the highest 
seropositivity when compared to others. Married subjects were more seropositive (38.6%) and there 
ZDVDVWDWLVWLFDODVVRFLDWLRQEHWZHHQWKHVXEMHFWV¶PDULWDOVWDWXVDQGWKHDcquisition of Dengue virus 
infection (X2 =29.461, P < 0.001) (Table I). Among the predisposing
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risk factors, rash history had a significant association with the acquisition of Dengue virus (P<0.05) 
(Table II). 
Female subjects (1.7%) predominated the observed concurrent infections (Table III). Surprisingly, the 
highest optical density (OD) value obtained from the Dengue virus IgM antibodies assay was 
2.086nm and was from a female with a concurrent infection. 
4. DISCUSSION 
Dengue virus outbreaks have persistently occurred in some part of Africa (Nigeria inclusive) for 
several decades, but many go unreported due to lack of diagnostic facilities [Baba et al., 2016]. The 
high prevalence of recent DENV infection (46.0%) recorded in this study which was conducted 
towards the decline of dry season when temperature was high could be linked to the effect warm 
temperature has on Aedes species [Reuda et al., 1990]. Warm temperature affects Aedes aegypti (the 
principle vector of Dengue virus) larval, thereby resulting in the development of smaller adult size. 
The smaller adult size females in turn tend to feed frequently on blood meal in order to nourish their 
developing eggs [Reita, 1988] which increase the tendency of Dengue virus transmission. However, 
Mohapatra et al. [2012] and Idris et al. [2013] recorded high prevalence in studies conducted during 
the mid-rainy season. 
The high prevalence of Dengue virus reported in this study is closely related to the studies of Adesina 
and Adeniji [2016] and Bello et al. [2016] that reported 25.7% and 51.9% respectively. The reason for 
WKHYDULDWLRQLQWKHSUHYDOHQFHUDWHFRXOGEHGXH WRUHVHDUFKHUV¶ LQWHUHVW LQVRPHVSHFLILFVHURW\SHV
While this study investigated all serotypes, researchers like Idris et al. [2015] were interested in 
serotype III which could have influenced the prevalence rate obtained. It could
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also be due to variation in climatic condition [Baba and Talle, 2011] and the different geographical 
locations where the studies were conducted [Baba et al., 2009]. 
Females were more seropositive for Dengue virus infection than males, but the acquisition of Dengue 
virus infection was not dependent on the sex of the subject. This finding is similar to other studies 
[Dawurung et al., 2010; Idris et al., 2013] that reported higher prevalence in females. 
In this study, it was noticed that some age groups seemed to be more exposed to the vector of Dengue 
virus than others. Adults within the age group 31-40 were the most infected (49.38%) when compared 
to other age groups. This is in line with the findings of Idris et al. [2013] where subjects seropositive 
to Dengue type III neutralizing antibodies were highest in age group 30-39. The reason for the high 
seropositivity in adults could be due to more exposure of the young adults to the vector in course of 
searching for means of livelihood. More than half of the married subjects enrolled in this study were 
seropositive. This negates the report of Adesina and Adeniji [2016] where the single individuals were 
more seropositive to Dengue IgM antibodies. 
Subjects with tertiary education dominated this study and it could be due to the presence of tertiary 
institutions like polytechnics, universities, college of education, etc. within the study area. More than 
half of the subjects who had no form of education were seropositive and it corresponds to the findings 
of Adesina and Adeniji [2016] where individuals with no form of education had Dengue infection the 
most. 
In this study, the type of house subjects live in seemed to influence the rate of Dengue virus 
acquisition. Subjects staying in flats had a significantly high number of seropositivity for Dengue IgM 
antibodies compared to subjects who live in other house types. The reason for the high
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seroprevalence of this group is unclear, but it could be attributed to the sanitary conditions of the 
houses. This finding contradicts an earlier study [Awando et al., 2013] that reported the acquisition of 
Dengue virus to be independent of house type. Majority of the subjects that indicated regular usage of 
mosquito nets were less seropositive to Dengue virus infection. The nets may have effectively 
interrupted the disease transmission cycle by restricting interaction between the vectors and the 
subjects [Onwujekwe et al., 2004]. 
Surprisingly, most of the subjects who claimed not to be exposed to certain risk factors (presence of 
stagnant water around homes, staying outdoors during the day, and rash history) were more 
seropositive to the virus compared to those exposed, which is similar to the report of Adesina and 
Adeniji [2016]. Apart from exposure to the virus, a number of reasons could lead to the establishment 
of the virus in the subjects. Some of these reasons include: level of immunity of the subjects, viral 
load infected with, previous exposure to the virus, as well as the nutritional level of the subjects. 
In this study, subjects who were not on any medication were more seropositive compared to those on 
medication. However, Idoko et al. [2015] reported seropositivity in all the subjects under antimalaria 
medication as compared to those who were not under medication. 
7KHXVHRI'HQJXHYLUXVXQLYHUVDOSULPHUDQGSUREHZKLFKWDUJHWVWKH¶875XQWUDQVODWHGUHJLRQRI
Dengue virus serotype 1-4 is important because it enables the detection of all Dengue virus serotypes. 
7KH¶875SOD\VDFUXFLDOUROHLQ'HQJXHYLUXVJHQHH[SUHVVLRQE\LQIOXHQFLQJWKHORFDOL]DWLRQDQG
translation efficiency of Dengue virus messenger RNA (mRNA) [Alm et al., 2014]. The RT-qPCR 
confirmed the presence of Dengue virus in Eleven (6.3%) of the twelve subjects who were positive 
for MAC-ELISA. The only negative subject observed following RT-
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qPCR could have been positive for MAC-ELISA due to cross reactivity from other species of the 
genus Flavivirus. This cross reactivity could easily occur when assaying for Dengue virus using 
Enzyme-Linked Immunosorbent Assay (ELISA). Previous studies [Baba and Talle, 2011; Baba et al., 
2013] suggest that Flaviviruses such as West Nile virus and yellow fever virus are in circulation in 
Nigeria. 
Out of the 11 samples confirmed, Dengue serotype 2 dominated and is related to an earlier study 
[Baba and Talle, 2011] that reported four out of five Dengue positive samples as Dengue serotype 2. 
Dengue serotype 3 and 4 were equally distributed, suggesting that the two serotypes are also in 
circulation in the study area, although there is paucity of data detailing Dengue serotypes in infected 
subjects. 
4.1 LIMITATION OF STUDY 
This study was conducted in a particular season. Inclusion of other periods of the season (e.g. early 
and mid-rainy season) could have significant impact on the prevalence of Dengue and malaria 
distribution. Furthermore, cross-reaction with other members of the Genus Flavivirus ZDVQ¶W
sufficiently ascertained because the RT-qPCR was not conducted for all the IgM positive Dengue 
samples. 
4.2 CONCLUSION 
The study has revealed a high prevalence of recent Dengue infection and low prevalence of malaria 
infection within Ilorin metropolis, Nigeria. Evidence of concurrent malaria and DENV infections 
were also presented. Infections with DENV serotype 2 was most predominant within the study area. 
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4.3 RECOMMENDATION 
The government should prioritize surveillance and mosquito control programs. Advanced 
research laboratories should be made available so as to aid adequate screening exercise and avoid 
misdiagnosis. In addition, medical practitioners should not be hasty in considering only malaria 
or typhoid when addressing febrile cases. 
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Table I: Seroprevalence of Dengue virus IgM antibodies among the febrile subjects with 
respect to socio-demographic factors (n=176). 
 
  
Parameters IgM positive IgM negative Total (%) X2 df P Value 
 (%) (%)     
Sex:    .150 1 .698 
Male 36 (20.5) 45 (25.6) 81 (46.0) 
   
Female 45 (25.6) 50 (28.4) 95 (54.0)    
Total 81 (46.02) 95 (53.95) 176 (100)    
Age: 
   
91.907 7 < 0.001 
0-10 3 (1.70) 10(5.68) 13 (7.38)    
11-20 2 (1.1) 21 (11.93 23 (13.03)    
21-30 3 (1.70) 46 (26.1) 49 (27.3)    
31-40 40 (22.72) 10 (5.7) 50 (28.4)    
41-50 18 (10.2) 7 (3.97) 25 (14. 2)    
51-60 9(5.1) 1 (0.56) 10 (5.7)    
61-70 4 (2.3) 0 4 (2.3)    
>70 2 (1.1) 0 2 (1.1)    
Total 81 (45. 9) 95 (53. 1) 176 (100)    
Marital Status: 
   
29.461 1 < 0.001 
Married 68 (38. 6) 42 (23.9) 110 (62.5)    
Single 13 (7.4) 53 (30.1) 66 (37.5)    
Total 81 (46 ) 95 (54 ) 176 (100)    
Occupation: 
   
19.963 3 < 0.001 
Farmer 10(5.7) 7 (4.0) 17 (9.7)    
Civil Servant 31(17.6) 26 (14.8) 57 (32.4)    
Business 31 (17.6) 23 (13.1) 54 (30.7)    
Student 9(5.1) 39 (22.2) 48 (27.3)    
Total 81 (46.0) 95 (54.0) 176 (100)    
X2-chi square, df - degree of freedom, P < 0.05 - statistical significance at 95% confidence level 
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Table II: Seroprevalence of Dengue virus IgM antibodies among subjects with respect to 
some predisposing risk factors. 
 
X2-chi square, P < 0.05 - statistical significance at 95% confidence level 
Predisposing Risk 
Factor 
 IgM 
Positive 
(%) 
IgM 
Negative 
(%) 
Total (%) X2 P3 
Value 
 
Usage of     .001     .982 
mosquito net Yes 24(13.6) 28(15.9) 52 (29.5)   
No 57 (32.4) 67 (38.1) 124 (70.5)   
 Total 81 (46.0) 95 (54.0) 176 (100)  
 
Presence of 
    
3.450 .063 
stagnant water Yes 8 (4.5) 19(10.8) 27(15.3)   
around No 73 (41.5) 76 (43.2) 149 (84.7)  
 
residence Total 81 (46.0) 95 (54.0) 176 (100)  
 
Staying outdoors 
    
.038      .845 
during the day Yes 44 (25.0) 53(30.1) 97 (55.1)   
No 37(21.0) 42 (23.9) 79 (44.9)  
 
 Total 81 (46.0) 95 (54.0) 176 (100)  
Travel within 
    
.572 .450 
the last 1 month Yes 38(21.6) 50 (28.4) 88 (50.0)  
  No 43 (24.4) 45 (25.6) 88 (50.0)  
 Total 81 (46.0) 95 (54.0) 176 (100)  
 
History of rash 
    
6.805     .009 
 Yes 10(5.7) 27(15.3) 37 (21.0)   
 No 71 (40.3) 68 (38.6) 139 (79.0)  
 
 Total 81 (46.0) 95 (54.0) 176 (100)  
Usage of 
    
.780 .377 
medication Yes 28(15.9) 39 (22.2) 67 (38.1)  
 
 No 53 (30.1) 56(31.8) 109 (61.9)  
 Total 81 (46.0) 95 (54.0) 176 (100)   
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Table III: Serotyping of Dengue Viral RNA using RT-qPCR 
S/N Patient 
Code 
Sex Age Group Day(s) 
Since Onset of 
Illness 
Threshold 
Cycle (CT 
Value) 
Dengue 
Virus IgM 
status 
Malaria 
status 
Dengue 
Virus 
Amplicons 
Dengue 
Serotype 
01 40 F 31-40 4 19.3 +ve +ve + 2 
02 23 F 31-40 2 19.7 +ve +ve + 4 
03 T57 F 41-50 3 19.7 +ve +ve + 4 
04 O44 M 51-60 3 No Ct +ve +ve - Nil 
05 O8 M >70 2 19.5 +ve +ve + 3 
06 O31 M 31-40 3 19.4 +ve - ve + 3 
07 4 F 21-30 1 19.5 +ve -ve + 2 
08 20 F 51-60 2 19.5 +ve -ve + 2 
09 O25 F >70 4 19.6 +ve -ve + 2 
10 T76 F 31-40 3 19.6 +ve -ve + 2 
11 24 M 0-10 2 19.6 +ve -ve + 2 
12 O16 F 0-10 2 19.5 +ve -ve + 2 
KEY : Positive 
Negative 
= +ve 
= -ve 
Present = + 
Absent = - 
Female = F 
Male = M 
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5 (2.8%) 
 
Figure I: Seroprevalence of Dengue virus IgM antibodies and concurrent infection among subjects 
  
 
Ŷ Dengue Virus IgM Positive 
Ŷ Dengue Virus IgM Negative 
Ŷ Dengue and Malaria Concurrent Infection 
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Figure 2. History of DENV infection in participants. In order to determine the history of DENV infection in participants, the presence of anti-DENV IgM 
(red bars) and IgG (blue bars) iQSDUWLFLSDQW¶VVHUXPVDPSOHVZHUHGHWHFWHGE\VDQGZLFK(/,6$3DUWLFLSDQW¶VVHUXPWKDWWHVWHGQHJDWLYHIRUDQWL-DENV IgM 
were further tested for anti-DENV IgG. Figure shows ELISA test results for participants (A) 001 - 044, (B) 045 - 088, (C) 089 - 132 and (D) 133 - 176. 
Optical density (OD) values were taken at 450 nm and are shown on the y-axes; assigned serial numbers for respective participant is shown on the x-axes. 
Positive cut-off values for IgM (red broken lines) and IgG (blue broken lines) are also shown. IgG data are omitted for participants 152, 155, 156 and 167 
owing to technical glitches with serum samples. 
